Rhenman & Partners Asset Management AB Sells 78,000 Shares of Tenet Healthcare Corporation $THC

Rhenman & Partners Asset Management AB trimmed its holdings in shares of Tenet Healthcare Corporation (NYSE:THC) by 57.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 58,429 shares of the company’s stock after selling 78,000 shares during the period. Rhenman & Partners Asset Management AB owned about 0.07% of Tenet Healthcare worth $11,863,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the stock. WCM Investment Management LLC grew its stake in shares of Tenet Healthcare by 244.4% in the third quarter. WCM Investment Management LLC now owns 510,224 shares of the company’s stock worth $102,657,000 after purchasing an additional 362,083 shares during the last quarter. AlphaQuest LLC increased its stake in shares of Tenet Healthcare by 238.3% during the third quarter. AlphaQuest LLC now owns 5,965 shares of the company’s stock valued at $1,211,000 after buying an additional 4,202 shares during the period. Winnow Wealth LLC purchased a new stake in Tenet Healthcare in the third quarter worth $1,129,000. Cerity Partners LLC increased its position in Tenet Healthcare by 10.4% during the 2nd quarter. Cerity Partners LLC now owns 120,623 shares of the company’s stock valued at $21,230,000 after purchasing an additional 11,395 shares during the period. Finally, Savant Capital LLC raised its holdings in Tenet Healthcare by 27.5% in the 3rd quarter. Savant Capital LLC now owns 16,894 shares of the company’s stock worth $3,430,000 after purchasing an additional 3,647 shares in the last quarter. 95.44% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Tenet Healthcare news, EVP Thomas W. Arnst sold 24,000 shares of the company’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $234.04, for a total transaction of $5,616,960.00. Following the transaction, the executive vice president owned 8,012 shares in the company, valued at approximately $1,875,128.48. This represents a 74.97% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Nadja West sold 2,178 shares of Tenet Healthcare stock in a transaction that occurred on Monday, December 15th. The stock was sold at an average price of $197.47, for a total transaction of $430,089.66. Following the completion of the sale, the director owned 28,480 shares of the company’s stock, valued at $5,623,945.60. This represents a 7.10% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 34,195 shares of company stock valued at $7,912,606. 0.81% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on THC. Wall Street Zen raised shares of Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Sunday, March 1st. JPMorgan Chase & Co. lifted their price objective on Tenet Healthcare from $200.00 to $230.00 and gave the company an “overweight” rating in a research report on Thursday, November 13th. Jefferies Financial Group increased their target price on Tenet Healthcare from $250.00 to $265.00 and gave the stock a “buy” rating in a research report on Thursday, February 12th. Morgan Stanley restated an “overweight” rating and set a $260.00 price target on shares of Tenet Healthcare in a research report on Thursday, February 12th. Finally, UBS Group increased their price objective on Tenet Healthcare from $260.00 to $288.00 and gave the stock a “buy” rating in a report on Thursday, February 12th. One research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, Tenet Healthcare currently has a consensus rating of “Moderate Buy” and a consensus price target of $247.67.

Tenet Healthcare Stock Performance

Shares of THC stock opened at $236.67 on Friday. The company’s 50-day moving average is $210.13 and its 200 day moving average is $202.29. The company has a market capitalization of $20.58 billion, a price-to-earnings ratio of 15.28, a price-to-earnings-growth ratio of 1.17 and a beta of 1.39. Tenet Healthcare Corporation has a one year low of $109.82 and a one year high of $247.21. The company has a debt-to-equity ratio of 2.18, a quick ratio of 1.68 and a current ratio of 1.76.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share for the quarter, beating the consensus estimate of $4.08 by $0.62. The company had revenue of $5.53 billion during the quarter, compared to the consensus estimate of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The firm’s quarterly revenue was up 8.9% compared to the same quarter last year. During the same quarter last year, the firm earned $3.44 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Sell-side analysts expect that Tenet Healthcare Corporation will post 12.24 EPS for the current fiscal year.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.